Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2002
- 4605; author reply 4606 p. digital
Publication Type: Comment; Letter
0732-183X
10.1200/JCO.2002.99.191 doi
Antineoplastic Agents, Hormonal--therapeutic use Biomarkers, Tumor--analysis Breast Neoplasms--chemistry Female Humans Predictive Value of Tests Receptor, ErbB-2--analysis Research Design Retrospective Studies